Carles Galdeano
- Molecular Biology top 10%
- Pharmacology top 1%
- Computational Theory and Mathematics top 1%
- Organic Chemistry top 5%
- Oncology top 10%
- Co-authors
- Alessio CiulliMorgan S. GaddPedro SoaresDiego Muñoz‐TorreroF. Javier LuqueDavid M. DiasInge Van MolleElisabet Viayna
- Topics
- Cholinesterase and Neurodegenerative Diseases (13 papers)Protein Degradation and Inhibitors (10 papers)Computational Drug Discovery Methods (8 papers)
- Journals
- Angewandte Chemie International EditionNature CommunicationsSHILAP Revista de lepidopterología
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Carles Galdeano
34 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 897
- Pharmacology 673
- Computational Theory and Mathematics 516
- Organic Chemistry 400
- Oncology 273
Countries citing papers authored by Carles Galdeano
This map shows the geographic impact of Carles Galdeano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Galdeano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Galdeano more than expected).
Fields of papers citing papers by Carles Galdeano
This network shows the impact of papers produced by Carles Galdeano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Galdeano. The network helps show where Carles Galdeano may publish in the future.
Co-authorship network of co-authors of Carles Galdeano
This figure shows the co-authorship network connecting the top 25 collaborators of Carles Galdeano. A scholar is included among the top collaborators of Carles Galdeano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carles Galdeano. Carles Galdeano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 9 | |
| 6 | 4 | |
| 7 | 49 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 1 | |
| 11 | 31 | |
| 12 | 178 | |
| 13 | 13 | |
| 14 | 37 | |
| 15 | 40 | |
| 16 | 15 | |
| 17 | 5 | |
| 18 | 8 | |
| 19 | 49 | |
| 20 | 78 |
About Carles Galdeano
Carles Galdeano is a scholar working on Pharmacology, Biochemistry and Computational Theory and Mathematics, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (13 papers), Protein Degradation and Inhibitors (10 papers) and Computational Drug Discovery Methods (8 papers). The work is most often cited by research in Pharmacology (673 citations), Computational Theory and Mathematics (516 citations) and Hematology (157 citations). Carles Galdeano has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Alessio Ciulli, Morgan S. Gadd, Pedro Soares, Diego Muñoz‐Torrero, F. Javier Luque, David M. Dias, Inge Van Molle, Elisabet Viayna, Pelayo Camps and Salvatore Scaffidi. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.